Search

everythinglearnresearchcommunity

for

Search:↓

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Use "female pattern hair loss" term, finasteride may help, more research needed.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Women with high androgen levels may have more severe COVID-19 symptoms.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

The document concludes that managing PCOS effectively requires considering ethnic differences, obesity's impact, and ethical concerns in treatment approaches.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

New treatments for PCOS are improving fertility and managing symptoms better.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.